 Management hypertension cardiovascular risk Blood pressure reduction hypertensive patients surrogate real therapeutic goal risks consequent hypertension surrogate convenient use important therapeutic implications Results treatment new antihypertensive agents data clinical trials insights underlying mechanisms overall success antihypertensive therapy undeniable frequency atherosclerosis coronary events metabolic disarray agents thiazides beta blockers Electrolyte abnormalities arrhythmias sudden death myocardial infarction Left ventricular hypertrophy chief risk factor coronary events arrhythmias heart failure antihypertensive agents progression renal injury sensitive agents Obesity hypertension Evidence atherogenic abnormalities common obese patients insulin resistance nonobese patient sensitive antihypertensive agent